VIROMED MEDICAL AG (VME.DE) Forecast, Price Target & Analyst Ratings

FRA:VMEDE000A40ZVN7

Current stock price

5.35 EUR
+0.05 (+0.94%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for VIROMED MEDICAL AG (VME.DE).

Forecast Snapshot

Consensus Price Target

Price Target
€10.20
+ 90.65% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
N/A

ChartMill Buy Consensus

Rating
82.86%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
€10.20
Upside
+ 90.65%
From current price of €5.35 to mean target of €10.20, Based on 7 analyst forecasts
Low
€10.10
Median
€10.20
High
€10.50

Price Target Revisions

1 Month
N/A
3 Months
N/A

Price Target Summary

7 Wall Street analysts provided a forecast for the next 12 months for VME.DE. The average price target is 10.2 EUR. This implies a price increase of 90.65% is expected in the next year compared to the current price of 5.35.

Analyst Ratings & History

Current Analyst Ratings

VME Current Analyst RatingVME Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

VME Historical Analyst RatingsVME Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -14 -13 -12 -11 -10 -9 -8 -7 -6 -5 -4 -3 -2 -1 0 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
82.86%
VME.DE was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about VME.DE.
In the previous month the buy percentage consensus was at a similar level.
VME.DE was analyzed by 7 analysts. More opinions would make the average more meaningful.

Recent Upgrades & Downgrades

Next Earnings Forecast Details

Next Earnings Details

Release Date
N/A

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

Full Analyst Estimates 2025 - 2027

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027
Revenue
YoY % growth
VME.DE revenue by date.VME.DE revenue by date.
N/AN/A
480.41%
N/A
67.14%
EBITDA
YoY % growth
VME.DE ebitda by date.VME.DE ebitda by date.
N/AN/A
700.00%
N/A
-12.50%
N/A
1,185.71%
N/A
108.89%
EBIT
YoY % growth
VME.DE ebit by date.VME.DE ebit by date.
-360K-440K
-22.22%
N/A
262.27%
N/A
1,171.43%
N/A
106.74%
Operating Margin
VME.DE operating margin by date.VME.DE operating margin by date.
N/AN/AN/AN/AN/A
EPS
YoY % growth
VME.DE eps by date.VME.DE eps by date.
N/AN/A
100.00%
N/AN/A
2,600.00%
N/A
125.93%

All data in EUR

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

VME.DE Yearly Revenue VS EstimatesVME.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 20M 40M 60M 80M
VME.DE Yearly EPS VS EstimatesVME.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2025 2026 2027 0 0.2 0.4 0.6

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A

VIROMED MEDICAL AG / VME.DE Forecast FAQ

What is the average price target for VIROMED MEDICAL AG (VME.DE) stock?

7 analysts have analysed VME.DE and the average price target is 10.2 EUR. This implies a price increase of 90.65% is expected in the next year compared to the current price of 5.35.

How many analysts cover VIROMED MEDICAL AG (VME.DE) stock?

The number of analysts covering VIROMED MEDICAL AG (VME.DE) is 7.